Raj Tummala
6PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|May 06, 2023
Clinical Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anifrolumab.Weifeng Tang, Raj Tummala, Joachim Almquist
|Jan 23, 2023
Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus.Eric F Morand, Gabriel Abreu, Richard A Furie
|Mar 11, 2022
Causal cascade of direct and indirect effects of anifrolumab on patient-reported outcomes: structural equation modelling of two Phase 3 trials.Donald Stull, Sean O'Quinn, Betsy Williams
|Sep 16, 2021
Relationship of anifrolumab pharmacokinetics with efficacy and safety in patients with systemic lupus erythematosus.Yen Lin Chia, Jianchun Zhang, Raj Tummala
|May 12, 2021
Anifrolumab reduces flare rates in patients with moderate to severe systemic lupus erythematosus.Richard Furie, Eric F Morand, Anca D Askanase
Pageof 1
Frequent Collaborators
2 joint publications
Eric F Morand
2 joint publications
Weifeng Tang
2 joint publications
Joachim Almquist
1 joint publications
Richard A Furie
1 joint publications
Michael Hwang
1 joint publications
Wendy I White
1 joint publications
Yen Lin Chia
1 joint publications
Lynn Bertagnolli
1 joint publications
David Jayne
1 joint publications
Catharina Lindholm